TCL Archive Socio-Economic Factors, Access To Care, Associated With More Aggressive Cancers April 27, 2007
TCL Archive Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds August 26, 2005
TCL Archive New FDA Commisioner’s Top Priorities: FDAMA Implimitation, Agency’s Science January 8, 1999
TCL Archive Biotherapeutics Reports LAK/IL-2 Toxicity Reduced With Constant Infusion Of IL-2 April 17, 1987